Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas. [electronic resource]
Producer: 20171107Description: 1354-1363 p. digitalISSN:- 1530-0307
- Adaptor Proteins, Signal Transducing -- antagonists & inhibitors
- Adult
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Biomarkers, Tumor -- metabolism
- Brain Neoplasms -- diagnosis
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cohort Studies
- Enzyme Activation -- drug effects
- Female
- Glioma -- diagnosis
- Humans
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Proteins -- antagonists & inhibitors
- Nerve Tissue Proteins -- antagonists & inhibitors
- Phosphoproteins -- antagonists & inhibitors
- Phosphorylation -- drug effects
- Prognosis
- Protein Processing, Post-Translational -- drug effects
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Transcription Factors
- YAP-Signaling Proteins
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.